Partner With Us
At Arcturis, we are passionate about working with our partners to harness the power of real-world health data to drive innovation in drug research and generate better outcomes for patients.
Who We Work With
Our relationship with our data and industry partners is central to our business. Arcturis has established strong collaborations with individual NHS hospitals over a number of years that enabled formation of our unique Real-World Data Network.
The purpose of the Real-World Data Network is to provide access and curate deep, enriched real-world data into research-ready datasets that Arcturis can use to support the research programmes our clients in the life sciences industry. The RWD Network has ethics approval from the UK Health Research Authority.
Through our partnership model, we aim to support innovation in the discovery, development and adoption of new medicines and improve patient outcomes.
NHS Partners
Arcturis collaborates with individual NHS trusts and regional hubs, alongside other research organisations and clinical opinion leaders through our HRA-approved Real-World Data Network to access enriched, regulatory-grade health data.
We invest into our NHS hospital partners to ensure the resources are available to support the curation of high-quality, research-ready health data into our research data platform. All data is provided on an anonymised basis with its provision operating under strict agreements that comply with NHS ethical oversight and governance requirements.
We are continuing to expand our Real-World Data Network to ensure we are able to meet the growing demand for use of real-world health data in the discovery, development and adoption of innovative new medicines.
Life Sciences Partners
Arcturis understands that research creates unique challenges. We work with our clients to tailor our highly curated and enriched data to your individual need so we can generate bespoke real-world evidence insights that enables better decision making and better outcomes for patients.
Our clients include top-tier global pharmaceutical companies, specialist pharmaceutical and biotechnology companies and AI and in silico drug discovery companies. Working with industry partners and clients is an important part of our business model, and we believe the combination of R&D efforts and domain expertise is crucial in driving success and more efficient outcomes for patients.